Ganymed Pharmaceuticals AG;Johannes Gutenberg-Universität Mainz, vertreten durch den Präsidenten
发明人:
申请号：
EP10011776.1
公开号：
EP2311879B1
申请日:
2006.11.24
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing CLD18, including tumor-related diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder.
